Literature DB >> 6173751

Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody.

R A Miller, D G Maloney, R Warnke, R Levy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6173751     DOI: 10.1056/NEJM198203043060906

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  167 in total

1.  [Monoclonal antibodies and immunoconjugates: new prospects in the treatment of non-Hodgkin's lymphomas].

Authors:  A Sack; P Meusers
Journal:  Strahlenther Onkol       Date:  1999-04       Impact factor: 3.621

2.  In vitro inhibition of tumor B cell growth by IgG-BF-producing Fc gamma RII+ T cell hybridoma and by immunoglobulin G-binding factors.

Authors:  C Mathiot; S Amigorena; J Moncuit; C Sautès; W H Fridman; J L Teillaud
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

Review 3.  Evaluation of current cancer immunotherapy: hemato-oncology.

Authors:  Christopher S Hourigan; Hyam I Levitsky
Journal:  Cancer J       Date:  2011 Sep-Oct       Impact factor: 3.360

4.  Dendritic cells loaded with apoptotic antibody-coated tumor cells provide protective immunity against B-cell lymphoma in vivo.

Authors:  Suzanne N Franki; Kristopher K Steward; David J Betting; Kamran Kafi; Reiko E Yamada; John M Timmerman
Journal:  Blood       Date:  2007-11-09       Impact factor: 22.113

Review 5.  Immunomodulation in the treatment of haematological malignancies.

Authors:  Michela Cesco-Gaspere; Emma Morris; Hans J Stauss
Journal:  Clin Exp Med       Date:  2009-02-24       Impact factor: 3.984

6.  A 3-dimensional tumor growth inhibition assay for testing monoclonal antibody cytotoxicity.

Authors:  W Z Wei; R J Massey; G H Heppner
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

Review 7.  Development of therapies for autoimmune disease at Stanford: a tale of multiple shots and one goal.

Authors:  Lawrence Steinman
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

8.  Ablation of human colon carcinoma in nude mice by 131I-labeled monoclonal anti-carcinoembryonic antigen antibody F(ab')2 fragments.

Authors:  F Buchegger; C Pfister; K Fournier; F Prevel; M Schreyer; S Carrel; J P Mach
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

9.  Rituximab for non-Hodgkin's lymphoma: a story of rapid success in translation.

Authors:  Andrew M Harrison; Nassir M Thalji; Alexandra J Greenberg; Carmen J Tapia; Anthony J Windebank
Journal:  Clin Transl Sci       Date:  2013-10-03       Impact factor: 4.689

10.  Chronic lymphocytic leukemia monitoring with a Lamprey idiotope-specific antibody.

Authors:  Hirotomo Nakahara; Brantley R Herrin; Matthew N Alder; Rosa Catera; Xiao-Jie Yan; Nicholas Chiorazzi; Max D Cooper
Journal:  Cancer Immunol Res       Date:  2013-10       Impact factor: 11.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.